485 related articles for article (PubMed ID: 17256150)
1. Analysis of extended HLA haplotypes in multiple sclerosis and narcolepsy families confirms a predisposing effect for the class I region in Tasmanian MS patients.
Rubio JP; Bahlo M; Stankovich J; Burfoot RK; Johnson LJ; Huxtable S; Butzkueven H; Lin L; Taylor BV; Speed TP; Kilpatrick TJ; Mignot E; Foote SJ
Immunogenetics; 2007 Mar; 59(3):177-86. PubMed ID: 17256150
[TBL] [Abstract][Full Text] [Related]
2. Evidence for the genetic role of human leukocyte antigens in low frequency DRB1*1501 multiple sclerosis patients in Israel.
Karni A; Kohn Y; Safirman C; Abramsky O; Barcellos L; Oksenberg JR; Kahana E; Karussis D; Chapman J; Brautbar C
Mult Scler; 1999 Dec; 5(6):410-5. PubMed ID: 10618697
[TBL] [Abstract][Full Text] [Related]
3. DRB1-DQA1-DQB1 loci and multiple sclerosis predisposition in the Sardinian population.
Marrosu MG; Murru MR; Costa G; Murru R; Muntoni F; Cucca F
Hum Mol Genet; 1998 Aug; 7(8):1235-7. PubMed ID: 9668164
[TBL] [Abstract][Full Text] [Related]
4. Genetic dissection of the human leukocyte antigen region by use of haplotypes of Tasmanians with multiple sclerosis.
Rubio JP; Bahlo M; Butzkueven H; van Der Mei IA; Sale MM; Dickinson JL; Groom P; Johnson LJ; Simmons RD; Tait B; Varney M; Taylor B; Dwyer T; Williamson R; Gough NM; Kilpatrick TJ; Speed TP; Foote SJ
Am J Hum Genet; 2002 May; 70(5):1125-37. PubMed ID: 11923913
[TBL] [Abstract][Full Text] [Related]
5. HLA class II associated risk and protection against multiple sclerosis-a Finnish family study.
Laaksonen M; Pastinen T; Sjöroos M; Kuokkanen S; Ruutiainen J; Sumelahti ML; Reijonen H; Salonen R; Wikström J; Panelius M; Partanen J; Tienari PJ; Ilonen J
J Neuroimmunol; 2002 Jan; 122(1-2):140-5. PubMed ID: 11777553
[TBL] [Abstract][Full Text] [Related]
6. Epistasis among HLA-DRB1, HLA-DQA1, and HLA-DQB1 loci determines multiple sclerosis susceptibility.
Lincoln MR; Ramagopalan SV; Chao MJ; Herrera BM; Deluca GC; Orton SM; Dyment DA; Sadovnick AD; Ebers GC
Proc Natl Acad Sci U S A; 2009 May; 106(18):7542-7. PubMed ID: 19380721
[TBL] [Abstract][Full Text] [Related]
7. Dissection of the HLA association with multiple sclerosis in the founder isolated population of Sardinia.
Marrosu MG; Murru R; Murru MR; Costa G; Zavattari P; Whalen M; Cocco E; Mancosu C; Schirru L; Solla E; Fadda E; Melis C; Porru I; Rolesu M; Cucca F
Hum Mol Genet; 2001 Dec; 10(25):2907-16. PubMed ID: 11741834
[TBL] [Abstract][Full Text] [Related]
8. HLA-DQB1*0602 determines disease susceptibility in a new "humanized" multiple sclerosis model in HLA-DR15 (DRB1*1501;DQB1*0602) transgenic mice.
Kaushansky N; Altmann DM; Ascough S; David CS; Lassmann H; Ben-Nun A
J Immunol; 2009 Sep; 183(5):3531-41. PubMed ID: 19648275
[TBL] [Abstract][Full Text] [Related]
9. Negative association of the HLA-DRB1*1502-DQB1*0601 haplotype with human narcolepsy.
Hohjoh H; Terada N; Honda Y; Juji T; Tokunaga K
Immunogenetics; 2001; 52(3-4):299-301. PubMed ID: 11220634
[No Abstract] [Full Text] [Related]
10. HLA class II haplotype and sequence analysis support a role for DQ in narcolepsy.
Ellis MC; Hetisimer AH; Ruddy DA; Hansen SL; Kronmal GS; McClelland E; Quintana L; Drayna DT; Aldrich MS; Mignot E
Immunogenetics; 1997; 46(5):410-7. PubMed ID: 9271631
[TBL] [Abstract][Full Text] [Related]
11. D6S265*15 marks a DRB1*15, DQB1*0602 haplotype associated with attenuated protection from type 1 diabetes mellitus.
Valdes AM; Thomson G; Graham J; Zarghami M; McNeney B; Kockum I; Smith A; Lathrop M; Steenkiste AR; Dorman JS; Noble JA; Hansen JA; Pugliese A; Lernmark A; ; ;
Diabetologia; 2005 Dec; 48(12):2540-3. PubMed ID: 16320082
[TBL] [Abstract][Full Text] [Related]
12. SNP mapping and candidate gene sequencing in the class I region of the HLA complex: searching for multiple sclerosis susceptibility genes in Tasmanians.
Burfoot RK; Jensen CJ; Field J; Stankovich J; Varney MD; Johnson LJ; Butzkueven H; Booth D; Bahlo M; Tait BD; Taylor BV; Speed TP; Heard R; Stewart GJ; Foote SJ; Kilpatrick TJ; Rubio JP
Tissue Antigens; 2008 Jan; 71(1):42-50. PubMed ID: 17971048
[TBL] [Abstract][Full Text] [Related]
13. Genetic and functional studies in multiple sclerosis patients from Martinique attest for a specific and direct role of the HLA-DR locus in the syndrome.
Quelvennec E; Bera O; Cabre P; Alizadeh M; Smadja D; Jugde F; Edan G; Semana G
Tissue Antigens; 2003 Feb; 61(2):166-71. PubMed ID: 12694585
[TBL] [Abstract][Full Text] [Related]
14. Association of susceptibility to multiple sclerosis in Southern Han Chinese with HLA-DRB1, -DPB1 alleles and DRB1-DPB1 haplotypes: distinct from other populations.
Wu XM; Wang C; Zhang KN; Lin AY; Kira J; Hu GZ; Qu XH; Xiong YQ; Cao WF; Gong LY
Mult Scler; 2009 Dec; 15(12):1422-30. PubMed ID: 19965521
[TBL] [Abstract][Full Text] [Related]
15. Identification of a telomeric boundary of the HLA region with potential for predisposition to human narcolepsy.
Miyagawa T; Hohjoh H; Honda Y; Juji T; Tokunaga K
Immunogenetics; 2000 Nov; 52(1-2):12-8. PubMed ID: 11132147
[TBL] [Abstract][Full Text] [Related]
16. Association of narcolepsy-cataplexy with HLA-DRB1 and DQB1 in Mexican patients: a relationship between HLA and gender is suggested.
Alaez C; Lin L; Flores-A H; Vazquez M; Munguia A; Mignot E; Haro R; Baker H; Gorodezky C
BMC Med Genet; 2008 Aug; 9():79. PubMed ID: 18706091
[TBL] [Abstract][Full Text] [Related]
17. Relative predispositional effects of HLA class II DRB1-DQB1 haplotypes and genotypes on type 1 diabetes: a meta-analysis.
Thomson G; Valdes AM; Noble JA; Kockum I; Grote MN; Najman J; Erlich HA; Cucca F; Pugliese A; Steenkiste A; Dorman JS; Caillat-Zucman S; Hermann R; Ilonen J; Lambert AP; Bingley PJ; Gillespie KM; Lernmark A; Sanjeevi CB; Rønningen KS; Undlien DE; Thorsby E; Petrone A; Buzzetti R; Koeleman BP; Roep BO; Saruhan-Direskeneli G; Uyar FA; Günoz H; Gorodezky C; Alaez C; Boehm BO; Mlynarski W; Ikegami H; Berrino M; Fasano ME; Dametto E; Israel S; Brautbar C; Santiago-Cortes A; Frazer de Llado T; She JX; Bugawan TL; Rotter JI; Raffel L; Zeidler A; Leyva-Cobian F; Hawkins BR; Chan SH; Castano L; Pociot F; Nerup J
Tissue Antigens; 2007 Aug; 70(2):110-27. PubMed ID: 17610416
[TBL] [Abstract][Full Text] [Related]
18. HLA class I alleles tag HLA-DRB1*1501 haplotypes for differential risk in multiple sclerosis susceptibility.
Chao MJ; Barnardo MC; Lincoln MR; Ramagopalan SV; Herrera BM; Dyment DA; Montpetit A; Sadovnick AD; Knight JC; Ebers GC
Proc Natl Acad Sci U S A; 2008 Sep; 105(35):13069-74. PubMed ID: 18765817
[TBL] [Abstract][Full Text] [Related]
19. HLA-DRB1-DQB1 haplotypes confer susceptibility and resistance to multiple sclerosis in Sardinia.
Cocco E; Sardu C; Pieroni E; Valentini M; Murru R; Costa G; Tranquilli S; Frau J; Coghe G; Carboni N; Floris M; Contu P; Marrosu MG
PLoS One; 2012; 7(4):e33972. PubMed ID: 22509268
[TBL] [Abstract][Full Text] [Related]
20. Conditional ETDT analysis of the human leukocyte antigen region in type 1 diabetes.
Koeleman BP; Herr MH; Zavattari P; Dudbridge F; March R; Campbell D; Barnett AH; Bain SC; Mulargia AP; Loddo M; Amos W; Cucca F; Todd JA
Ann Hum Genet; 2000 May; 64(Pt 3):215-21. PubMed ID: 11246473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
